Our objective at Onxeo is to maintain an open, rich dialogue with our shareholders, our potential investors and the financial community at large. We keep you informed on a regular basis of the progress made by the Company in order to help you with your analysis and make it easier for you to understand the Company’s added value.

Agenda >

Direct Dirigeants retail event

November 6, 2019

Molecular Targets & Cancer Therapeutics’ (AACR-NCI-EORTC)

October 26-30, 2019

Galien MedStart'Up

October 23-24, 2019

Investir Day

October 3, 2019